These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 27784282)
1. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Dookie N; Sturm AW; Moodley P BMC Infect Dis; 2016 Oct; 16(1):609. PubMed ID: 27784282 [TBL] [Abstract][Full Text] [Related]
2. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235 [TBL] [Abstract][Full Text] [Related]
3. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273 [TBL] [Abstract][Full Text] [Related]
4. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737 [TBL] [Abstract][Full Text] [Related]
5. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic. Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660 [TBL] [Abstract][Full Text] [Related]
6. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116 [TBL] [Abstract][Full Text] [Related]
7. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes? Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557 [TBL] [Abstract][Full Text] [Related]
8. Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand. Suthum K; Samosornsuk W; Samosornsuk S J Infect Dev Ctries; 2020 Mar; 14(3):268-276. PubMed ID: 32235087 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa. Pitso L; Potgieter S; Van der Spoel van Dijk A S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590 [TBL] [Abstract][Full Text] [Related]
10. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China. Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465 [TBL] [Abstract][Full Text] [Related]
11. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases. Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637 [TBL] [Abstract][Full Text] [Related]
12. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance. Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359 [TBL] [Abstract][Full Text] [Related]
13. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan. Munir S; Mahmood N; Shahid S; Khan MI Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. Al-Mutairi NM; Ahmad S; Mokaddas EM Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020 [TBL] [Abstract][Full Text] [Related]